Abilify was first approved by the U.S. Food and Drug Administration (FDA) to treat schizophrenia in November 2002. Read more
A judge has ordered the maker of Risperdal to pay $327 million in civil penalties to the state of South Carolina for its marketing of the antipsychotic drug. The case was filed by the state... Read more
In an excellent article, written jointly by Margaret Fisk, Jef Feeley, and David Voreacos for Bloomberg, some disturbing revelations involving Johnson & Johnson, a major drug manufacture... Read more
A study has found that heart attack risks were doubled in people taking widely-used antipsychotic drugs in a study that found the medicines are no safer than the older medications they have... Read more
Eli Lilly and Co., the Indianapolis drug maker, will settle an investigation by federal and state authorities over the antipsychotic Zyprexa. The government’s investigation is related... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.